Jove
Visualize
Contact Us

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

9.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.6K
Urinary Tract Calculi VI: Surgical Management01:25

Urinary Tract Calculi VI: Surgical Management

190
Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...
190

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intermediate clinical endpoints as surrogates for overall survival after salvage prostatectomy.

BJU international·2026
Same author

Quality of life in patients undergoing surgical correction of the exstrophy-epispadias complex in childhood.

World journal of urology·2026
Same author

Assessing the efficacy of pelvic floor muscle training and duloxetine on urinary continence recovery following radical prostatectomy: A randomized clinical trial.

The Prostate·2023
Same author

Revisiting Delphi to Create a Basis for the Future of Focal Therapy for Prostate Cancer.

The world journal of men's health·2023
Same author

Robotic-Assisted Partial Nephrectomy: Techniques to Improve Clinical Outcomes.

Current urology reports·2021
Same author

Current state of image-guided focal therapy for prostate cancer.

World journal of urology·2020
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Dec 5, 2025

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

439

Ablative options for prostate cancer management.

Rafael R Tourinho-Barbosa1,2,3, Lucas Teixeira Batista3, Xavier Cathelineau1

  • 1Department of Urology, Institute Mutualiste Montsouris, Université Paris-Descartes, Paris, France.

Turkish Journal of Urology
|October 14, 2020
PubMed
Summary
This summary is machine-generated.

Partial gland ablation (PGA) offers a low-toxicity approach for prostate cancer (PCa) management, including primary treatment and repeat ablation. While recurrence rates are higher than whole-gland methods, PGA shows promise for localized PCa.

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.6K
Focal Laser Ablation of Prostate Cancer: An Office Procedure
11:07

Focal Laser Ablation of Prostate Cancer: An Office Procedure

Published on: March 30, 2021

8.2K

Related Experiment Videos

Last Updated: Dec 5, 2025

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

439
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.6K
Focal Laser Ablation of Prostate Cancer: An Office Procedure
11:07

Focal Laser Ablation of Prostate Cancer: An Office Procedure

Published on: March 30, 2021

8.2K

Area of Science:

  • Urology
  • Oncology
  • Medical Technology

Background:

  • Prostate cancer (PCa) management traditionally involves whole-gland treatments.
  • Emerging technologies enable targeted ablation of prostate lesions.
  • Partial gland ablation (PGA) is gaining traction for localized PCa.

Purpose of the Study:

  • To review available ablative options for prostate cancer (PCa) management.
  • To discuss the role of prostate ablation in various clinical settings.
  • To evaluate the efficacy and toxicity of partial gland ablation (PGA).

Main Methods:

  • Review of current literature on prostate cancer ablation techniques.
  • Analysis of ablative concepts utilizing thermal, mechanical, and vascular-targeted energy sources.
  • Examination of studies reporting outcomes for partial gland ablation (PGA).

Main Results:

  • Partial gland ablation (PGA) demonstrates a favorable toxicity profile compared to whole-gland treatments.
  • PGA shows encouraging short-term oncological outcomes in recent series and prospective studies.
  • Repeat ablation for recurrent disease exhibits low toxicity, warranting further investigation.

Conclusions:

  • Partial gland ablation (PGA) is a promising, low-toxicity option for various prostate cancer (PCa) management scenarios.
  • While recurrence rates may be higher, PGA offers a less harmful alternative to radical treatments.
  • Long-term oncological data are needed to establish PGA as a standard treatment option.